WAT

Waters Corporation (WAT) - Q2 2026 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended July 4, 2026. The period is defined by the completion of the BDS Business Acquisition (Becton, Dickinson and Company's Biosciences and Diagnostic Solutions business) on February 9, 2026. This transaction, valued at approximately $13 billion, was structured as a Reverse Morris Trust. Consequently, the company reorganized into three reportable segments: Analytical & Materials Sciences, Biosciences, and Advanced Diagnostics. The financial results for the BDS Business are included from the closing date forward.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Surge: Total revenue increased 113% in Q2 and 103% YTD, driven primarily by the inclusion of BDS Business revenue ($817 million in Q2; $1.3 billion YTD). Excluding BDS, legacy revenue grew 7% in Q2 and 10% YTD.
• Profitability Decline: The company reported an operating loss of $86 million in Q2 and $134 million YTD, compared to operating income of $188 million and $340 million in the prior year periods. This shift is attributed to significant non-cash acquisition-related expenses, including $244 million in purchased intangibles amortization (Q2) and $253 million in inventory/fixed asset fair value step-up expenses (YTD).
• Balance Sheet Expansion: Total assets increased from $5.1 billion to $24.8 billion, and total debt rose from $1.4 billion to $5.1 billion to fund the acquisition. Goodwill increased from $1.3 billion to $9.4 billion.
• Restructuring: The company implemented a workforce reduction impacting ~3% of employees, incurring $49 million in severance costs in Q2 and $52 million YTD.

Guidance, Outlook, and Risks

• Outlook: Management expects foreign currency translation to be neutral to gross profit for the remainder of 2026. The workforce reduction is projected to yield approximately $120 million in annual salary-related cost savings.
• Integration Costs: The company is incurring significant transaction, integration, and ERP implementation costs. A Transition Services Agreement (TSA) with BD is in place for up to three years at an estimated annual cost of $90 million.
• Tariffs and Trade: The company faces uncertainty regarding U.S. tariffs and potential refunds following a Supreme Court ruling on IEEPA tariffs. New tariffs under alternative statutory authority have been implemented, creating potential supply chain and cost structure risks.
• Deferred Close Businesses: Certain assets in China and Italy have not legally transferred yet. The company has recorded a $129 million prepaid deposit asset for these businesses and recognizes revenue on a gross basis via the TSA.

Investor Verification Checklist

• Acquisition Accounting: Verify the final purchase price allocation and potential adjustments to goodwill and intangible assets during the measurement period (up to one year from closing).
• Debt Covenants: Confirm continued compliance with leverage and interest coverage ratios given the significant increase in debt load ($5.1 billion).
• Working Capital: Monitor the $673 million receivable due from BD related to the TSA, which significantly impacts Days Sales Outstanding (DSO) and operating cash flow.
• Legacy Growth: Assess organic growth rates of the legacy Analytical & Materials Sciences segment, which grew 7-10% excluding the BDS impact.
• Tariff Exposure: Evaluate the impact of new U.S. trade policies and the timing of potential tariff refunds on future margins.